These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38613220)

  • 1. Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) Scores > 55 at 6 Months Postoperative Predict Ability to Achieve Patient Acceptable Symptomatic State at Minimum 1 Year Postoperative Following Autologous Chondrocyte Implantation for Grade IV Chondral Defects About the Patellofemoral Joint.
    Retzky JS; Fletcher C; Rizy M; Burge A; Strickland SM
    Cartilage; 2024 Apr; ():19476035241244491. PubMed ID: 38613220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patellar and trochlear cartilage lesions with matrix-induced autologous chondrocyte implantation in conjunction with patellofemoral realignment procedures improves patient-reported outcomes and magnetic resonance image appearance.
    Retzky JS; Carey EG; Selley RS; Fletcher C; Hartwell MJ; Burge AJ; Gomoll A; Strickland S
    J ISAKOS; 2024 Oct; 9(5):100311. PubMed ID: 39154863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of 2-Year Outcomes in Patients Undergoing Tibiofemoral or Patellofemoral Matrix-Induced Autologous Chondrocyte Implantation.
    Ebert JR; Schneider A; Fallon M; Wood DJ; Janes GC
    Am J Sports Med; 2017 Dec; 45(14):3243-3253. PubMed ID: 28910133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining Patient-relevant Thresholds and Change Scores for the HOOS JR and KOOS JR Anchored on the Patient-acceptable Symptom State Question.
    Dekhne MS; Fontana MA; Pandey S; Driscoll DA; Lyman S; McLawhorn AS; MacLean CH
    Clin Orthop Relat Res; 2024 Apr; 482(4):688-698. PubMed ID: 37773026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the Minimal Clinically Important Difference and Patient Acceptable Symptom State for Microfracture of the Knee: A Psychometric Analysis at Short-term Follow-up.
    Chahla J; Kunze KN; Tauro T; Wright-Chisem J; Williams BT; Beletsky A; Yanke AB; Cole BJ
    Am J Sports Med; 2020 Mar; 48(4):876-883. PubMed ID: 32058796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of Minimal Clinically Important Difference, Substantial Clinical Benefit, and Patient-Acceptable Symptomatic State for Commonly Used Patient-Reported Outcomes in Recurrent Patellar Instability Patients After Medial Patellofemoral Ligament Reconstruction and Tibial Tubercle Transfer.
    Qiao Y; Wu C; Wu X; Li Z; Chen J; Xu C; Zhao S; Zhao J
    Arthroscopy; 2024 Jan; 40(1):115-123. PubMed ID: 37419222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the Minimal Clinically Important Difference and Patient-Acceptable Symptomatic State After Arthroscopic Meniscal Repair and Associated Variables for Achievement.
    Maheshwer B; Wong SE; Polce EM; Paul K; Forsythe B; Bush-Joseph C; Bach BR; Yanke AB; Cole BJ; Verma NN; Chahla J
    Arthroscopy; 2021 Dec; 37(12):3479-3486. PubMed ID: 33964390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing Clinically Significant Outcomes After Meniscal Allograft Transplantation.
    Liu JN; Gowd AK; Redondo ML; Christian DR; Cabarcas BC; Yanke AB; Cole BJ
    Orthop J Sports Med; 2019 Jan; 7(1):2325967118818462. PubMed ID: 30643837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good clinical and MRI outcome after arthroscopic autologous chondrocyte implantation for cartilage repair in the knee.
    Siebold R; Suezer F; Schmitt B; Trattnig S; Essig M
    Knee Surg Sports Traumatol Arthrosc; 2018 Mar; 26(3):831-839. PubMed ID: 28258330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral to slightly undercorrected mechanical leg alignment provides superior long-term results in patients undergoing matrix-associated autologous chondrocyte implantation.
    Weishorn J; Koch KA; Zietzschmann S; Trefzer R; Walker T; Renkawitz T; Bangert Y
    Knee Surg Sports Traumatol Arthrosc; 2024 Aug; 32(8):2040-2051. PubMed ID: 38738859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained superiority in KOOS subscores after matrix-associated chondrocyte implantation using spheroids compared to microfracture.
    Hoburg A; Niemeyer P; Laute V; Zinser W; Becher C; Kolombe T; Fay J; Pietsch S; Kuźma T; Widuchowski W; Fickert S
    Knee Surg Sports Traumatol Arthrosc; 2023 Jun; 31(6):2482-2493. PubMed ID: 36269383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Minimal Clinically Important Difference, Substantial Clinical Benefit, and Patient-Acceptable Symptomatic State after Medial Patellofemoral Ligament Reconstruction.
    Walsh JM; Huddleston HP; Alzein MM; Wong SE; Forsythe B; Verma NN; Cole BJ; Yanke AB
    Arthrosc Sports Med Rehabil; 2022 Apr; 4(2):e661-e678. PubMed ID: 35494257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Cell Dose on the Early Magnetic Resonance Morphological Outcomes of Autologous Cell Implantation for Articular Cartilage Defects in the Knee: A Randomized Clinical Trial.
    Niemeyer P; Laute V; John T; Becher C; Diehl P; Kolombe T; Fay J; Siebold R; Niks M; Fickert S; Zinser W
    Am J Sports Med; 2016 Aug; 44(8):2005-14. PubMed ID: 27206690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent clinical and radiological outcomes after both open flake refixation and autologous chondrocyte implantation following acute patella dislocation and concomitant flake fractures.
    Ehmann YJ; Zuche L; Schmitt A; Berthold DP; Rupp MC; Muench LN; Otto A; Woertler K; Imhoff AB; Mehl J
    Knee Surg Sports Traumatol Arthrosc; 2022 Oct; 30(10):3334-3342. PubMed ID: 35218374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous Chondrocyte Implantation Improves Knee-Specific Functional Outcomes and Health-Related Quality of Life in Adolescent Patients.
    Cvetanovich GL; Riboh JC; Tilton AK; Cole BJ
    Am J Sports Med; 2017 Jan; 45(1):70-76. PubMed ID: 27566240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Hydrogel-Based Autologous Chondrocyte Implantation Versus Microfracture: A Propensity Score Matched-Pair Analysis.
    Niemeyer P; Angele P; Spiro RC; Kirner A; Gaissmaier C
    Orthop J Sports Med; 2023 Aug; 11(8):23259671231193325. PubMed ID: 37655236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroids for Patellofemoral or Tibiofemoral Defects: A 5-Year Follow-up of a Phase 2, Dose-Confirmation Trial.
    Hoburg A; Niemeyer P; Laute V; Zinser W; John T; Becher C; Izadpanah K; Diehl P; Kolombe T; Fay J; Siebold R; Fickert S
    Orthop J Sports Med; 2022 Jan; 10(1):23259671211053380. PubMed ID: 35071653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations and treatment outcomes for patellofemoral articular cartilage defects with autologous chondrocyte implantation: prospective evaluation at average 4-year follow-up.
    Pascual-Garrido C; Slabaugh MA; L'Heureux DR; Friel NA; Cole BJ
    Am J Sports Med; 2009 Nov; 37 Suppl 1():33S-41S. PubMed ID: 19861699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinically Important Difference and Patient Acceptable Symptomatic State for Commonly Used Patient-Reported Outcomes After Knee Cartilage Repair.
    Chahal J; Lansdown DA; Davey A; Davis AM; Cole BJ
    Am J Sports Med; 2021 Jan; 49(1):193-199. PubMed ID: 33226845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cartilage defects in the patellofemoral joint with matrix-associated autologous chondrocyte implantation effectively improves pain, function, and radiological outcomes after 5-7 years.
    Eichinger M; Henninger B; Petry B; Schuster P; Herbst E; Wagner M; Rosenberger R; Mayr R
    Arch Orthop Trauma Surg; 2024 Apr; 144(4):1655-1665. PubMed ID: 38206448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.